The Linear Correlation of Serum Level  Thrombospondin-1 with Lipid Profile in Patients with Diabetic Disease Type II

Wijdan Rajh Hamza  Al-Kraity

doi:10.46966/msjar.v1i01.5

Authors

Wijdan Rajh Hamza Al-Kraity Department Medical Laboratories Techniques, Al-Toosi University College, Iraq

DOI:

https://doi.org/10.46966/msjar.v1i01.5

Keywords:

Type II diabetic mellitus, Lipid profile and TSP-1

Abstract

The study was conducted on randomly selected 65 type 2 diabetic patients attending the diabetes mellitus center in Al-Sadder Teaching City in Al- Najaf province , Iraq and a group of 24 apparently healthy subjects were included as a control group . The Study was carried out from August 2013 to February 2014.The patients' age was ranging of 35 to 64 years old.The results indicated a significant increase (p<0.05) in serum TSP-1 , Cholesterol, TG,VLDL-C, LDL-C levels and a significant decrease (p>0.05) in serum HDL-C level in diabetic patients in comparing with healthy groups. The results have been shown significant positive correlation (P<0.05) TSP-1 and cholesterol, TSP-1 and TG, TSP-1 and LDL-C, TSP-1 and VLDL-C in DM patients. The results have been shown significant negative correlation (P<0.05) between TSP-1 and HDL-C in type 2 diabetic patients.

References

Adams, J.C., and Lawler, J. (2004). The thrombospondins. Int. J. Biochem. Cell Biol., 36:961-968.

Alemzadeh, R. ;Wyatt, D.T.; Behrman, R.E.; Kliegman, R.M. and Jenson, H.B. (2008). Diabetes mellitus in children. Nelson Textbook of Pediatrics. 18th ed. Philadelphia: Saunders, 2404-31.

Al-Kraity, W.R.H. and Arshad Noori Ghani Al-Dujaili, A.N.G, (2016). Assessment of Thrombospondin-1 Level in Type II Diabetic Patients. RJPBCS., 7(6) PP. 1201 -1210.

Bauer, E.M. ; Qin, Y.; Miller, T.W. ; Bandle, R.W. ; Csanyi, G. ; Pagano, P.J. ; Bauer, P.M. ; Schnermann, J. ; Roberts, D.D. ;

Isenberg, J.S. (2010).Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation. Cardiovasc. Res., 88:471–481.

Canadian Diabetes Association (CDA). (2008). Clinical Practice Guideline for the Prevention and Management of Diabetes in Canada. Canadian Journal of Diabetes, 32(1):S1-S201.

Canadian Diabetes Association(CDA). (2013). Definition, Classification and Diagnosis of Diabetes: Prediabetes and Metabolic Syndrome. Can. J. Diabetes, 37:S8-S11

Choi, K-Y.; Kim, D-B.; Kim, M-J.; Kown, B-J. ;Chang, S-Y. et al.(2012). Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus. Korean Circulation Journal, 42:100-106.

Dabir, P. ; Marinic, T.E. ; Krukovets, I. and Stenina, O.I. (2008). Aryl-hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells. Circ. Res., 102:65-1558.

Gonzalez-Quesada, C.; Cavalera, M.; Biernacka, A.; Kong, P.; Lee, D.W.; Saxena, A.; Frunza, O.; Dobaczewski, M.; Shinde, A.V. and Frangogiannis, N.G.(2013).Thrombospondin-1 Induction in the Diabetic Myocardium Stabilizes the Cardiac Matrix, While Promoting Vascular Rarefaction Through Angiopoietin-2 Upregulation. Circ. Res., 113(12):1331-44.

Ii, M.; Takenaka, H.; Asai, J.; Ibusuki, K.; Mizukami, Y.; Maruyama, K. et al.(2006). Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury. Circ. Res., 98:697-704.

Jimenez, B.; Volpert, O.V.; Crawford, S.E.; Febbraio, M.; Silverstein, R.L. and Bouck, N. (2000). Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med., 6: 41-48.

Khan, H.A. (2006). Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients. Acta. Diabetol.,1-8.

Kong, P.; Gonzalez-Quesada, C.; Li, N.; Cavalera, M.; Lee, D.W. and Frangogiannis, N.G.(2013a). Thrombospondin-1 regulates adiposity and metabolic dysfunction in dietinduced obesity enhancing adipose inflammation and stimulating adipocyte proliferation. Am. J. Physiol. Endocrinol. Metab., 305:E439-50.

Kong, P. ; Cavalera, M. and Frangogiannis, N.G.(2013b). The role of thrombospondin-1 (TSP-1) in obesity and diabetes. Adipocyte , 3:1:1-4.

Leahy, J. L. and William, T. (2002). insulin Therapy. 1st ed. New York: Marcel Dekker. ISBN.0-8247-0711-7.

Lopez-Dee, Z.; Pidcock, K. and Gutierrez, L.S. (2011). Thrombospondin-1: Multiple paths to inflammation. Mediators Inflamm.,1-10.

Maier, G.M. ; HAN, X. ; Sadowitz, B.; Gentile, K.L.; Middleton, F.A. and Gahton, V. (2009). Thrombospondin-1: A proatherosclerotic protein augmented by hyperglycemia. Journal of Vascular Surgery , 51(5):1238-1247.

Meng, H. ; Zhang, X. ; Lee, S.J. ; Strickland, D.K. ; Lawrence, D.A. and Wan, M.M. (2010). enhancement of Notch3 signaling regulates Thrombospondin-2 (TSP2) LDL-receptor related protein (LRP1). J. Biol. Chem.,1-24.

Murphy, R.; Ellard, S. and Hattersley, A.T.(2008). Clinical implications of a molecular genetic classification of monogenic β–cell diabetes. Nature Clinical Practice Endocrinology and Metabolism, 4: e200.

Murphy-Ullrich, J.E. and Poczatek, M.(2000). Activation of latent TGF-beta by thrombospondin1: mechanisms and physiology. Cytokine Growth Factor Rev., 11: 59–69.

Orr, A.W.; Pedraza ,C.E.; Pallero, M.A.; Elzie, C.A.; Goicoechea, S.; Strickland, D.K. et al.(2003a). Low density lipoprotein receptor-related protein is a calreticulin co-receptor that signals focal adhesion disassembly. The Journal of Cell Biology,161:1179–1189.

Orr, A.W. ; Elzie, C.A. ;Kucik, D.F. ;Murph-ullrich, J.E. (2003b). Thrombospondin signaling through the calreticulin/LDL receptor-related protein co-complex stimulates random and directed cell migration. Journal of Cell Science, 116 (14), 2917-2927.

Qian, X. and Tuszynski, G.P.(1996). Expression of thrombospondin-1 in cancer: A role in tumor progression. Proc. Soc. Exp. Biol. Med., 212: 199–207.

Raman, P.; Krukovets, I.; Marinic, T.E.; Bornstein, P. and Stenina, O.I.(2007).Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J. Biol. Chem., 282:5704-14.

Roth, J.J.; Gahtan, V.; Brown ,J.L.; Gerhard, C.; Swami, V.K.; Rothman, V.L. et al.(1998). Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J. Surg. Res., 74:11-6.

Thabrew, I. and Ayling, R.M. (2001). Biochemistry for clinical Medicine. 1st ed. Green wich Medical Media ttd. London. Pp.166-167.

Wahab, N.A.; Schaefer, L.; Weston, B.S. et al.(2005).Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli. Diabetologia, 48: 2650–2660.

Yevdokimova, N. ; Wahab, N.A. and Mason, R.M.(2001). Thrombospondin-1 is the key activator of TGF-b1 in human mesangial cells exposed to high glucose. J. Am. Soc. Nephrol., 12: 703–712.